The Wall Street Journal
@WSJ
Sign up for our newsletters and alerts: | Got a tip? | For WSJ customer support:
Joined April 2007
1.1K Following 22.3M Followers
AstraZeneca is readying to file the first of a new portfolio of targeted cancer drugs for regulatory approval, moving to cement its position in one of the fastest-growing corners of the oncology market.
Show more
